MDS Pharma Services Strengthens Medical Leadership in Phase IIa Clinical Research



    Dr. Ross Tonkens will lead medical affairs and provide consultation to
    clients

    KING OF PRUSSIA, PA, Aug. 28 /CNW/ - MDS Pharma Services, a leading
provider of innovative drug discovery and development solutions, has hired
Ross Tonkens, MD, to provide medical oversight for its Phase IIa clinical
research activities and to direct the medical and clinical activities of its
Development & Regulatory Services line of business. As Vice President -
Medical Affairs, Dr. Tonkens will design clinical study protocols, provide
medical consultation to clients, and chair the company's Development &
Regulatory Services Medical Advisory board. In addition, Dr. Tonkens will
represent MDS Pharma Services and serve as the 2008 Chair of the Ethics &
Clinical Practice Committee of ACRO, the Association of Clinical Research
Organizations.
    "Medical oversight is critically important to participant safety in all
stages of drug development, and particularly during clinical proof of concept
studies, which are conducted with patients who have the disease state targeted
by the experimental drug," said MDS Pharma Services President David Spaight.
"We're proud to offer our clients access to the caliber of medical expertise
possessed by Dr. Tonkens. His experience spans academia, biotechnology and the
contract research organization industry."
    Prior to joining MDS, Dr. Tonkens was Chief Medical Officer of Regado
Biosciences, a Duke University biotechnology spin-off, and was Global Head of
Cardiovascular Therapeutics at Quintiles, Inc., a contract research
organization. A graduate of Yale College and Yale Medical School, Dr. Tonkens
practiced invasive cardiology in Beverly Hills, and was Assistant Clinical
Professor of Medicine at UCLA and the University of Nevada. Dr. Tonkens later
founded his own clinical research center and served as principal investigator
in more than 40 clinical trials in areas ranging from cardiology, pulmonary
disease, peripheral vascular disease and critical care to infectious disease,
gastroenterology, pain management and vaccine development.

    About MDS Pharma Services

    MDS Pharma Services is committed to delivering quality service on time.
We offer a full spectrum of resources to meet the drug discovery and
development needs of the pharmaceutical and biotechnology industries. With
numerous facilities strategically located around the world, we apply advanced
scientific and technological expertise throughout the drug discovery and
development process - from lead optimization, pre-IND research, early clinical
research (bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized cardiac
services. For more information, visit our website at www.mdsps.com.
    MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE:   MDZ),
a global life sciences company that provides market-leading products and
services that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 5,500 highly skilled people in
29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222,
24 hours a day.





For further information:

For further information: For Investors: Kim Lee, (416) 675-6777 ext.
34721, kim.lee@mdsinc.com; For Media: Charlene McGrady, (610) 239-7900 ext.
231, charlene.mcgrady@mdsinc.com

Organization Profile

Nordion Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890